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Mitochondrial DNA (mtDNA) encodes proteins that
are important forATPbiogenesis. Therefore, changes
in mtDNA copy number will have profound conse-
quences on cell survival and proliferation. RECQ4
DNA helicase participates in both nuclear DNA and
mtDNA synthesis. However, the mechanism that
balances the distribution of RECQ4 in the nucleus
and mitochondria is unknown. Here, we show that
RECQ4 forms protein complexes with Protein Phos-
phatase 2A (PP2A), nucleophosmin (NPM), and mito-
chondrial p32 in different cellular compartments.
Critically, the interaction with p32 negatively controls
the transport of both RECQ4 and its chromatin-asso-
ciated replication factor, MCM10, from the nucleus to
mitochondria. Amino acids that are deleted in the
most common cancer-associated RECQ4 mutation
are required for the interaction with p32. Hence, this
RECQ4 mutant, which is no longer regulated by p32
and is enriched in the mitochondria, interacts with
the mitochondrial replication helicase PEO1 and in-
duces abnormally high levels of mtDNA synthesis.INTRODUCTION
Mitochondria (MT) are key cellular organelles that generate ATP
for diverse cellular processes that are necessary to support cell
growth, and deterioration of MT and mtDNA contributes to the
aging process (Lee and Wei, 2012). Furthermore, accumulating
evidence also suggests there is an intimate connection between
MT dysfunction and cancer development (Carew et al., 2004;
D’Souza et al., 2007; Jeon et al., 2007; Lan et al., 2008). Because
themtDNA copy number positively correlates with the rate of cell
growth (Jeng et al., 2008), deregulated mtDNA synthesis could
be a risk factor that contributes to carcinogenesis or sustains
the rapid proliferation of cancer cells once they are established.
For this reason, in recent years, MT have gained attention both
as a potential diagnostic tool and as a therapeutic target for can-
cer therapy (Yu, 2011).848 Cell Reports 7, 848–858, May 8, 2014 ª2014 The AuthorsIn mammals, the members of the conserved RECQ helicase
family are important for nuclear DNA replication and damage
repair, and have also been suggested to participate in mtDNA
maintenance (de Souza-Pinto et al., 2010). Among the five
RECQ helicases identified, RECQ4, which is an essential gene
in vertebrates (Abe et al., 2011; Ichikawa et al., 2002), has
been observed in both the nucleus andMT (Chi et al., 2012; Cro-
teau et al., 2012; Yin et al., 2004). Indeed, multiple regions of
RECQ4 are required for its nuclear localization (Burks et al.,
2007), and it was suggested that a potential MT-targeting signal
is located within the first 20 amino acids (De et al., 2012). Muta-
tions in RECQ4 have been linked to three clinical diseases
that feature premature-aging phenotypes and a predisposition
to develop osteosarcoma and lymphoma (Liu, 2010). Through
its unique N terminus, RECQ4 forms chromatin-specific protein
complexes that contain the essential nuclear replication factors
MCM10 and the CDC45-MCM2-7-GINS (CMG) helicase (Xu
et al., 2009), and initiate DNA replication (Im et al., 2009; Sangrithi
et al., 2005; Thangavel et al., 2010). In addition to reducing
nuclear DNA replication, RECQ4 deficiency decreases mtDNA
copy number and the energy-production capacity of MT (Chi
et al., 2012; Croteau et al., 2012). However, the molecular mech-
anism that balances the distribution of RECQ4 in the nucleus and
MT remains to be defined.
In this study, we identified three RECQ4 interacting proteins:
PP2A, NPM, and MT p32. We determined that p32 promotes
the nuclear localization of RECQ4 by suppressing its trans-
port to MT. Importantly, the most common cancer-associated
RECQ4 mutation, c.1390+2 delT, which deletes Ala420–
Ala463 (Siitonen et al., 2009), produces a protein that cannot
interact with p32. Individuals homozygous or compound het-
erozygous for this internal deletion (ID) in the RECQ4 protein
develop RAPADILINO syndrome, and 40% of these patients
develop cancers that are primarily lymphomas. We found that
the RECQ4 ID mutant protein relocalized from the nucleus to
MT, where it accumulated. As a consequence, an excess
amount of RECQ4 mutant protein was able to interact with
the MT replication helicase PEO1 and led to an increase in
mtDNA synthesis, and an enhanced use of the glycolysis
pathway in preference to oxidative phosphorylation (OXPHOS).
Our data provide insights into how the intracellular location of
RECQ4 is regulated, as well as RECQ4’s potential link to cancer
etiology.
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Figure 1. The Lymphoma-Prone RECQ4 ID Mutant Is Catalytically
Active
(A) Schematic diagrams of WT RECQ4 and the lymphoma-associated RECQ4
ID mutant, which lacks residues A420–A463. The conserved SFII helicase
domain is shown in light gray.
(B) Sequence alignment of the human RECQ4 (A420–A463 aa) with the cor-
responding regions of the M. mulatta and M. musculus RECQ4 proteins.
Conserved residues are shown in black.
(C) RecombinantWTRECQ4 and ID proteins purified from E. coli, separated by
SDS-PAGE, and stained with Coomassie blue.
(D) Comparison of the ATPase activities of the WT RECQ4 and ID proteins in
the presence of ssDNA.
(E) DNA strand-exchange activities of the WT RECQ4 and ID proteins were
measured using 32P-end-labeled splayed-arm substrates in the presence or
absence of unlabeled oligos containing the identical sequence to the 32P-end-
labeled strand of the splayed arm substrates. The X01 strand of the splay-arm
substrate was labeled with 32P.
(F) Recombinant RECQ4 ID and ID-K508R (KR) double mutants purified from
E. coli, separated by SDS-PAGE, and stained with Coomassie blue.
(G) DNA strand-exchange activities of the RECQ4 ID and ID-K508R (KR)
proteins were measured as described in (E).RESULTS
The Lymphoma-Prone RECQ4 ID Mutant Protein Is
Catalytically Active
Ala420–Ala463 residues, which are unique to primates and are
missing in the lymphoma-prone RECQ4 ID mutant, are located
between the essential N terminus and the conserved Superfam-
ily Helicase Domain II (SFII; Figures 1A and 1B). Structure predic-
tionsmade using the GOR4 Secondary Structure Prediction ToolandGlobPlot suggest that these residues are disordered and un-
likely to affect the folding of the adjacent domains. Indeed, we
found that purified recombinant RECQ4 ID protein has ATPase
activity similar to that of the wild-type (WT) RECQ4 protein (Fig-
ures 1C and 1D). RECQ4 also exhibits strong single-stranded
DNA (ssDNA) annealing activity and can efficiently carry out
ATP-dependent DNA strand-exchange reactions, such that the
32P-labeled strand of a splayed arm substrate is dissociated as
a ssDNA product and replaced by an unlabeled ssDNA contain-
ing the same sequence (Figure 1E; Xu and Liu, 2009). Previously,
we showed that RECQ4 possesses dual DNA strand-exchange
activities: one controlled by the SFII domain and one located
within the N-terminal domain (Xu and Liu, 2009). We found that
suppressing the SFII domain by introducing the K508R mutation
weakened, but did not abolish, the DNA strand-exchange activ-
ity (Figures 1F and 1G), indicating that the SFII and N-terminal
domains of the RECQ4 ID mutant are both catalytically active.
The Lymphoma-Prone RECQ4 ID Mutant Protein
Supports DNA Replication
We next determined the effect of the RECQ4 ID mutant on cell
growth and nuclear DNA replication. First, we generated 293T,
U2OS, and HT1080 cell lines that stably expressed a RECQ4
short hairpin RNA (shRNA), which, as expected, reduced the
proliferation rate of the cells (Figures 2A, 2B, S1A, and S1B).
The stable RECQ4 shRNA-knockdown cells were then trans-
fected with shRNA-resistant plasmids that expressed either
FLAG-taggedRECQ4WTor the IDmutant protein at comparable
levels (Figures 2C and S1C). The FLAG-tagged RECQ4 proteins
were expressed at approximately 2- to 4-fold higher levels
compared with the endogenous RECQ4 protein (Figures S2A
and S2B). Interestingly, the stable expression of RECQ4 ID, but
not the WT protein, was toxic to HT1080 cells. Nevertheless,
we found that expressing the ID mutant, but not the vector, facil-
itated the growth rate of the RECQ4 shRNA knockdown 293T
and U2OS cells as efficiently as the WT protein (Figures 2D
and S1C). Furthermore, cell-cycle analysis confirmed that the
RECQ4 ID cells progressed through S phase at a rate similar to
that observed for the cells expressing theWT protein (Figure S3).
Human RECQ4 localizes to both the cytoplasm and the nu-
cleus (Burks et al., 2007; Yin et al., 2004; Figure S2C). Consistent
with this, we found that the exogenously expressed FLAG-
RECQ4 WT also localized to the cytoplasm and nucleus in
various human cell lines (Figure S2D). Previously, it was sug-
gested that the Ala420–Ala463 residues may contain a potential
nuclear retention signal (Burks et al., 2007). Indeed, we saw a
decreased amount of RECQ4 ID on human chromatin (CB) and
a proportional increase of the protein in the cytoplasm (CE; Fig-
ure 2E, top two panels). Immunofluorescent microscopy also
showed that the nuclear localization of RECQ4 ID mutant was
reduced (Figure S4). However, despite the reduction, the mutant
was still able to form a complex with the MCM proteins on DNA
(Figure 2F). Furthermore, a higher percentage of the RECQ4 ID
protein bound to chromatin was in complexes with nuclear
replication factors compared with the WT protein (Figure 2F).
We suggest that this increase in percentage could compensate
for the decreased amount of RECQ4 ID that is chromatin
bound. Altogether, our results indicate that the lymphoma-proneCell Reports 7, 848–858, May 8, 2014 ª2014 The Authors 849
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Figure 3. The Lymphoma-Associated RECQ4 ID Mutant Is Enriched
in MT and Promotes mtDNA Synthesis
(A) The copy number of mtDNA compared with genomic DNAwas quantified in
cells stably transfected with control or RECQ4 shRNA. Data are represented
as means ± SD from three independent experiments.
(B) MT fractions were isolated from WT RECQ4 or ID cells by centrifuging the
CE extracts to pellet theMT. The supernatant that was depleted ofMT proteins
was collected and designated as the Cyt fraction. Protein levels of RECQ4,
MCM2-7 (MCM4), and p53 were analyzed on western blots of the Cyt and MT
fractions (5 mg per lane). VDAC1 was used as the loading control of MT.
(C) Protein levels of RECQ4, MCM10, p53, and mtSSB inside the MT were
determined by trypsin digest of the intact MT followed byMT lysis and western
blotting. Proteins that were resistant to trypsin digest were localized inside the
MT; 25 mg of the MT extracts was used in each sample.
(D) PCR analysis to detect nuclear DNA (lower panel, Lamin B) and mtDNA
(upper panel, mt D-loop) using DNA template prepared from total genomic
DNA (lane 1), purifiedmtDNA from either RECQ4WT or ID cells, with or without
BrdU labeling (lanes 2–5). For mt D-loop PCR, 3 ng of DNA was used as
template, whereas 60 ng of DNA was used for Lamin B PCR.
(E) Dot blot analysis for BrdU in the indicated amounts of mtDNA prepared
from either RECQ4 WT or ID cells, with or without BrdU labeling.
(F) mtDNA copy number relative to genomic DNA was quantified in cells
expressing either the WT RECQ4 or the ID mutant. Data are represented as
means ± SD from three independent experiments.
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Figure 2. The Lymphoma-Prone RECQ4 ID Mutant Forms CB
RECQ4-MCM Complexes and Supports Cell Growth
(A) Protein levels of RECQ4 were analyzed using rabbit RECQ4 antibody on
western blots of WCEs prepared from HEK293T cells stably expressing a
control vector or RECQ4 shRNA. Actin was used as the loading control.
(B) The effect of RECQ4 knockdown by shRNA on cell growth wasmeasured in
crystal violet cell proliferation assays. Results are means ± SDs from three
separate wells. Data are representative of three independent experiments.
(C) Protein levels of the WT RECQ4 and ID mutant were analyzed using rabbit
RECQ4 antibody on western blots of WCE prepared from RECQ4 shRNA
knockdown cells that stably expressed vector alone or shRNA-resistant FLAG-
RECQ4 WT or ID mutant protein.
(D) Cell proliferation rates were compared among RECQ4 shRNA knockdown
cells complemented with empty vector, an shRNA-resistant WT FLAG-RECQ4
expression construct, or a plasmid expressing the FLAG-RECQ4 ID mutant
protein from (C). Results are means ± SDs from three separate wells. Data are
representative of three independent experiments.
(E) Protein levels of RECQ4, MCM10, MCM2-7 (represented by MCM4 and
MCM7), CDC45, and GINS (represented by SLD5 and PSF2) were analyzed on
western blots of CE, NE, and soluble CB fractions that were prepared fromWT
RECQ4 or ID cells.
(F) Western blots of the immunopurified FLAG complexes from the soluble
CB fractions (left three lanes) prepared from cells expressing vector, FLAG-
RECQ4WT, or FLAG-RECQ4 ID. The immunopurified complexes were probed
with antibodies to detect RECQ4, MCM10, MCM2-7 (MCM7), CDC45, and
GINS (SLD5).RECQ4 ID mutant protein is capable of forming functional repli-
cation helicase complexes that support DNA synthesis and cell
growth.
MT Dysfunction in Cells Expressing the RECQ4 ID
Mutant Protein
RECQ4 has been implicated in mtDNA maintenance (Chi et al.,
2012; Croteau et al., 2012). Indeed, the 293T cells we depleted
of RECQ4 contained less mtDNA than control knockdown cells850 Cell Reports 7, 848–858, May 8, 2014 ª2014 The Authors(Figure 3A). Therefore, we determined whether the increased
amount of RECQ4 ID protein in the cytoplasm led to increased
MT localization. The CE fraction (Figure 2E) contained both cyto-
solic (Cyt) and MT proteins. Therefore, we further separated the
CE extract into Cyt and MT proteins, and found that the
increased amount of RECQ4 ID protein was located primarily
in MT (Figures 3B, S5A, and S5B). Trypsin proteolysis of intact
MT confirmed that there was an increased amount of RECQ4 ID
protein in theMTmatrix (Figure 3C), which is where themtDNA is
located. This result raised the possibility that mtDNA synthesis
could be abnormal in RECQ4 IDmutant cells. To test this hypoth-
esis, we isolated mtDNA from WT- and ID-expressing cells that
had been pulse labeled with bromodeoxyuridine (BrdU) to
monitor DNA synthesis. PCR analysis confirmed that the mtDNA
we prepared from these cells contained little contaminating nu-
clear DNA (Figure 3D). By performing western blotting using a
BrdU antibody and comparing equal amounts of purifiedmtDNA,
we found that mtDNA isolated from the ID cells incorporated
higher levels of BrdU compared with mtDNA from WT-express-
ing cells (Figure 3E). This result explained the increased mtDNA
copy number we observed in RECQ4 ID cells compared with WT
cells (Figures 3F, S5C, and S5D). Interestingly, we found that the
difference between the amount of MTWT and ID RECQ4 protein
was greatest in HT1080 cells that were transiently transfected
with the RECQ4 WT or ID mutant (Figure S5B). In addition, an
elevated mtDNA copy number was observed within 2 days
of the transient transfection (Figure S5D). These observations
may explain why we were unsuccessful in establishing an
HT1080 cell line that stably expressed RECQ4 ID protein. There
was also an increase in CE MCM10 in the RECQ4 ID cells (Fig-
ure 2E), which was due to MCM10 also being enriched in the
MT fraction (Figure 3C). Because RECQ4 normally interacts
with MCM10 in the nucleus (Xu et al., 2009), the excess
RECQ4 ID protein and MCM10 that localized to the MT were
most likely transported directly from the nucleus. Nevertheless,
trypsin analysis indicated that MCM10 remained at the MT outer
membrane and did not enter the matrix (Figure 3C). On the other
hand, the localization of p53 to the MT, which is dependent on
RECQ4 (De et al., 2012), was unchanged in RECQ4 ID-express-
ing cells (Figures 3B, 3C, S5A, and S5B).
Overexpression of PEO1 leads to a high mtDNA copy number
andmtDNA deletions (Ylikallio et al., 2010), suggesting that rapid
mtDNA synthesis could contribute to mtDNA mutagenesis.
BecausemtDNA encodes components of the OXPHOS complex
required for ATP production, increasing themtDNA copy number
could affect the expression or function of the OXPHOS pathway.
We used nuclear magnetic resonance (NMR) to analyze the
metabolites of total cell extracts, which allowed us to quantita-
tively measure MT-associated metabolites, such as intermedi-
ates of the tricarboxylic citric acid (TCA) cycle that are present
at high cellular concentrations. We found that the cellular
concentrations of malate, NADH, oxoglutarate, and ATP were
decreased in RECQ4 ID cells compared with WT cells (Figures
4A, 4B, and S6). In contrast, lactate and amino acid levels
were increased in ID cells (Figures 4A, 4B, and S6), indicating
that MT function is reduced in RECQ4 ID cells and there is an
elevated rate of glycolysis in the Cyt (Figure 4C). This phenome-
non is known as theWarburg effect and is frequently observed in
cancer cells (Vander Heiden et al., 2009).
Protein-Protein Interactions with Human RECQ4
Our data indicate that the 44 amino acids missing from the lym-
phoma-prone RECQ4 ID mutant are required to block its trans-
port from the nucleus to the MT, and we hypothesized that this
negative regulation is accomplished via protein-protein interac-tions. To identify factors that regulate the localization of
RECQ4 to MT, we performed a large-scale immunopurification
of FLAG-RECQ4 WT protein as previously described (Xu et al.,
2009), except that we used the nonchromatin fractions (e.g., a
combination of CE and nucleoplasmic [NE] extracts; Figure 5A).
We used 293T cells without FLAG protein expression to subtract
out nonspecific polypeptides in the immunoprecipitated sample
(Figure 5A, left lane), and we identified PP2A, NPM, and MT p32
as the most abundant copurified proteins (Figures 5B and S7).
Using antibodies specific to RECQ4, we further confirmed that
PP2A, NPM, and p32 copurified with the endogenous RECQ4
proteins in 293T cells (Figure 5C).
PP2A is a serine/threonine phosphatase that is important for
regulating cell growth (Janssens and Goris, 2001), and cell frac-
tionation revealed that the majority of PP2A was cytosolic
(Figure 5D). NPM is an essential and multifunctional chaperone
protein that is known to shuttle among several cellular com-
partments, including the nucleolus, nucleoplasm, and cyto-
plasm (Falini et al., 2007). NPM has been implicated in regu-
lating centrosome duplication, chromatin remodeling, ribosome
biogenesis, and maintaining genome stability (Lindstro¨m,
2011). We found that NPM was predominantly detected in the
NE fraction andon the chromatin-bound (CB) fraction (Figure 5D).
Thep32protein, also knownasgC1qRorHABP1, residesprimar-
ily in the MT (Figure 5D), where it is thought to regulate MT innate
immune responses, OXPHOS for ATP biogenesis, and protein
localization to theMT, suchas in thecaseof the tumor suppressor
ARF (Fogal et al., 2010; Itahana and Zhang, 2008; Muta et al.,
1997; West et al., 2011). Nonetheless, even though each of
these RECQ4-interacting proteins seemed to concentrate in
distinct cellular compartments, they appeared to be mobile
and could also be present in multiple cellular compartments
(Figure 5D).
Next, we determined the cellular compartments in which
RECQ4 interacted with these proteins by immunopurifying
FLAG-RECQ4 from the Cyt, MT, NE, and CB fractions. We
asked which RECQ4-interacting proteins were enriched in
RECQ4 complexes purified from specific cellular compartments
when compared with RECQ4 complexes purified from whole-
cell extracts (WCEs). We found that PP2A, which is located pri-
marily in the Cyt (Figure 5D), was detected mainly in the Cyt
RECQ4 complex (Figure 5E). The most stable interaction be-
tween p32 and RECQ4 was found in the MT (Figure 5F).
NPM, which was found mostly in the nucleus, interacted with
RECQ4 primarily in the NE (Figure 5G) but could also associate
with CB RECQ4 (Figure 5H). Previously, NPM was not detected
in purified RECQ4 CB complexes, which were isolated after a
standard 2 hr benzonase digestion of the chromatin pellet (Xu
et al., 2009). The CB RECQ4-NPM complex was only detected
when the chromatin was digested with benzonase overnight,
suggesting that CB RECQ4-NPM complexes are likely to
be tightly associated with condensed regions of the chromo-
somes, such as heterochromatin. Interestingly, even though
MCM10 interacted preferentially with RECQ4 on chromatin (Fig-
ure 5H), a weak amount of MCM10 was detected in the MT
RECQ4 complex (Figure 5F). This is consistent with our obser-
vation that suggests MCM10 can be cotransported to the MT
with RECQ4.Cell Reports 7, 848–858, May 8, 2014 ª2014 The Authors 851
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Figure 4. RECQ4 WT and ID Cells Exhibit Different MT Metabolic Profiles
(A) Representative 1H NMR spectra of the hydrophilic metabolites extracted fromWT (green) and ID mutant (red) cells with expanded upfield (top) and downfield
(bottom) regions. The intensity scale of the downfield region is increased in order to show the resonances clearly.
(B) Concentrations of the metabolites that show statistically significant differences (p < 0.05) between the WT (green) and ID mutant (red) cells. For plotting
convenience, the concentrations of oxypurinol shown are 10-fold lower than the actual concentrations.
(C) Schematic diagram of the metabolic pathways affected by the RECQ4 ID mutant. The red and blue arrows represent increased and decreased metabolite
concentrations, respectively, in the ID mutant cells compared with the WT cells.The Interaction of the Lymphoma-Associated RECQ4 ID
Mutant Protein with MT p32 Is Defective
We next determined whether the interaction of RECQ4 with
PP2A, NPM, or p32 was altered by the RECQ4 ID mutation.
We found that PP2A and NPM copurified with both the RECQ4
WT and ID proteins, but p32 failed to copurify with the ID mutant
(Figures 6A, S5E, and S5F). The loss of the p32 interaction coin-
cided with a significant increase of the MT replication helicase
PEO1 in the purified RECQ4 ID complexes (Figures 6A, S5E,
and S5F). This result suggested the possibility that the interac-
tion of RECQ4 with p32 and PEO1 is mutually exclusive. Using
purified recombinant GST-p32 or GST-PEO1 bound to gluta-
thione beads, incubated with either purified recombinant
RECQ4 WT and ID mutant protein (Figure 6B), we confirmed852 Cell Reports 7, 848–858, May 8, 2014 ª2014 The Authorsthat GST-p32 was able to directly interact with RECQ4 WT, but
not the ID mutant (Figure 6C, lanes b and c). Furthermore, the
interaction with p32 mapped to the RECQ4 N terminus (Fig-
ure 6B, 1–492 aa; Figure 6C, lane e), which contains the 44 amino
acids that are missing in the ID mutant. In contrast, both RECQ4
WT and ID mutant interacted with PEO1 (Figure 6C, lanes f
and g). Even though the N-terminal fragment of RECQ4 exhibited
a strong interaction with PEO1, a weaker interaction was also
detected using a C-terminal fragment in vitro (Figure 6B, 450–
1,208 aa; Figure 6C, lanes h and i).
To test whether p32 can affect the interaction between RECQ4
and PEO1, we incubated purified recombinant PEO1 protein
tagged with chitin-binding domain (CBD) and anchored on
chitin beads with recombinant RECQ4, p32, or the RECQ4-p32
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Figure 5. Distinct RECQ4 Protein Com-
plexes Identified from Different Cellular
Compartments
(A) Purification and identification of non-CB
FLAG-RECQ4 complexes from human cells. The
immunopurified FLAG-RECQ4 complexes were
separated on 4%–15% gradient SDS-PAGE and
then silver stained.
(B) List of the polypeptides that were reproducibly
identified in non-CB RECQ4 complexes by mass
spectrometry (left), the number of peptides de-
tected (center), and their corresponding molecular
weight (right). Only those polypeptides that were
not present in the control immunoprecipitation
without FLAG expression and were specific to the
RECQ4 complex are listed.
(C) Western blots of the input (left) and im-
munopurified protein complexes isolated using
control IgG (center) or RECQ4-specific antibodies
(right), probed with antibodies to detect RECQ4,
MCM10, PP2A, NPM, and p32.
(D) The protein levels of NPM, p32, PP2A, and
MCM10 were analyzed on western blots of Cyt,
MT, NE, and soluble CB fractions prepared from
HEK293T cells. Tubulin, VDAC1, Lamin A, and
Histone H3 were used as markers for Cyt, MT, NE,
and CB, respectively.
(E–H) Western blots of the input (left 2 lanes) and
FLAG-RECQ4 WT complexes immunopurified
(right two lanes) fromWCEs and (E) Cyt, (F) MT, (G)
NE, and (H) CB fractions probed with antibodies to
detect the presence of RECQ4, MCM10, PP2A,
NPM, and p32.complex. As expected, CBD-PEO1 was able to pull down FLAG-
RECQ4, but it failed to do so when RECQ4 was preincubated
with p32 (Figure 6D, compare lanes e and g). In contrast,
MCM10, which interacts with the N terminus of RECQ4 (Xu
et al., 2009), did not block the RECQ4-PEO1 interaction (Fig-
ure 6D, compare lanes e and i). Interestingly, we found that
PEO1 also interacted directly with p32 and MCM10 in vitro, but
only the PEO1-p32 interaction was significantly weakened in
the presence of RECQ4 (Figure 6D, lanes f–i). These results
reveal a unique function for p32 in negatively regulating the
RECQ4-PEO1 interaction.
p32 Negatively Regulates Transport of RECQ4 to MT
Next, we tested whether p32 plays a role in controlling the
transport of RECQ4 to the MT. Indeed, depleting p32 by small
interfering RNA (siRNA) increased the amount of RECQ4 and
MCM10 in MT, and there was a corresponding decrease in
nuclear RECQ4 and MCM10 levels (Figures 7A and 7B). Inter-Cell Reports 7, 848estingly, in NPM-depleted cells, p32
accumulated in the Cyt fraction, which
resulted in a modest decrease in the
amount of MT p32 (Figure 7C). This
observation reveals an unexpected func-
tional interaction between NPM and p32
that has not been previously described,
and provides an explanation for the slightbut noticeable increase of RECQ4 in the MT of NPM knockdown
cells (Figure 7A). Importantly, because the RECQ4 ID mutant
protein failed to interact with p32, it could no longer be regulated
by p32, and therefore, as expected, depleting p32 had little
effect on the localization and accumulation of the RECQ4 ID
mutant to the MT (Figure 7A). Indeed, in contrast to what was
observed for cells expressing RECQ4 WT proteins, depleting
p32 from cells expressing the RECQ4 ID mutant did not signifi-
cantly increase the mtDNA copy number (Figure 7D). Altogether,
these results demonstrate a function for p32 in controlling the
amount of RECQ4 that is transported to the MT.
DISCUSSION
Synthesis of nuclear DNAandmtDNA is known to be coordinated
during the cell cycle (Chatre and Ricchetti, 2013). Mammalian
RECQ4 is an essential enzyme that is involved in the synthesis
of both nuclear DNA and mtDNA (Croteau et al., 2012; Liu,–858, May 8, 2014 ª2014 The Authors 853
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Figure 6. The Lymphoma-Associated
RECQ4 ID Mutant Cannot Interact with p32
(A) Western blots of the immunopurified FLAG
complexes from WCEs (left three lanes) prepared
from cells expressing vector, FLAG-RECQ4WT, or
FLAG-RECQ4 ID. The immunopurified complexes
were probed with antibodies to detect RECQ4,
MCM10, NPM, PP2A, p32, and PEO1.
(B) Schematic diagrams of RECQ4 WT and frag-
ments used in the in vitro pull-down experiments
shown in (C). The conserved SFII helicase domain
is shown in light gray.
(C) Western blots of the recombinant FLAG-
RECQ4WT and fragments before (upper) and after
(center) pull-down, using purified recombinant
GST, GST-p32, and GST-PEO1 (bottom) bound to
the glutathione beads.
(D) Western blots of the recombinant FLAG-
RECQ4, GST-p32, and GST-MCM10 before
(upper three panels) and after (center three panels)
pull-down using purified recombinant CBD and
CBD-PEO1 bound to the chitin beads (bottom
panel).2010). Our study demonstrates that the Ala420–Ala463 residues,
which are missing in the most common and highly cancer-prone
RECQ4 ID mutation, play a crucial role in balancing the distribu-
tion of RECQ4 between the nucleus and MT, and provides an
explanation for the decreased nuclear retention observed previ-
ously for this RECQ4 mutant (Burks et al., 2007). We provide
evidence that supports our conclusion that the excess RECQ4
ID mutant proteins found in the MT were transported from the
nucleus. First, the increased amount of RECQ4 IDmutant protein
in theMTwas accompanied by decreased levels of CB ID protein
(Figures 2E, 2F, 3B, and 3C). Second, MCM10, which is the pri-
mary protein that interacts with RECQ4 on human chromatin,
also showed increased MT localization in RECQ4 ID cells (Fig-
ure 3C). Finally, we identified three proteins (PP2A, NPM, and
p32) that interactedwithRECQ4 in variouscellular compartments
(Figure 5), and showed that the RECQ4 ID mutant cannot bind to
p32 in humancells (Figure 6A). Lossof p32binding led to anaccu-
mulation of the RECQ4 mutant protein in the MT, an enhanced
level of interaction of RECQ4 ID with the MT replication helicase
PEO1, and increases in mtDNA synthesis. Consistent with a role
for p32 as a negative regulator of RECQ4 transport from the
nucleus to the MT, depletion of p32 is also sufficient to disrupt
the balance of the CB and MT distribution of WT RECQ4 and
MCM10 (Figures 7A and 7B).
Future work is needed to define the exact molecular mecha-
nism by which p32 prevents RECQ4 and MCM10 from localizing
to the MT. p32 is also known to localize to the nucleus, although
to a lesser extent, and participate in cellular processes that
involve nuclear proteins (Brokstad et al., 2001). Possibly,
RECQ4 and MCM10 transiently interact with p32 in the nucleus.
We suggest that p32 could be a component of the protein-shut-854 Cell Reports 7, 848–858, May 8, 2014 ª2014 The Authorstling system between MT and the nu-
cleus. In support of this, p32 promotes
the nuclear import of adenovirus core
protein V (Matthews and Russell, 1998)and translocation of the tumor suppressor ARF to MT to activate
p53-dependent apoptosis (Itahana and Zhang, 2008). Alterna-
tively, the interaction of RECQ4 with p32 at MT may provide a
negative feedback signal or prevent interaction with other MT
protein(s), such as PEO1, whose interaction with RECQ4 is
mutually exclusive to p32 (Figure 6D), to limit the MT association
and entry of RECQ4.
Interestingly, even though both RECQ4 and MCM10 can be
found in MT, only the RECQ4 protein was transported into the
MT matrix, and MCM10 remained mostly at the outer MT mem-
brane (Figure 3C). It is possible that upon being transported to
the MT, RECQ4 dissociates from MCM10 via other protein-pro-
tein interaction(s), such as with PEO1. However, when we tested
the possibility that PEO1 disrupts the RECQ4-MCM10 interac-
tion in vitro, we found this was not the case (Figure 6D). Alter-
natively, posttranslational modifications might play a role in
modulating the localization and interactions of RECQ4with other
proteins. In support of this, we have shown that the RECQ4-
MCM10 interaction may be disrupted by potential CDK-depen-
dent phosphorylation (Xu et al., 2009). We also observed that
RECQ4 was present in multiple phosphorylation states in vivo
(J.-T.W. and Y.L., unpublished data). Similarly, RECQ4 phos-
phorylation may also regulate the p32-RECQ4 interaction to
allow a limited amount of RECQ4 to enter MT and promote
mtDNA synthesis.
In addition toMCM10, RECQ4 promotes theMT localization of
the p53 tumor suppressor (De et al., 2012). In this study, we
found that although the RECQ4 ID mutant accumulated in the
MT, the p53 level in MT was unaffected (Figures 3B and 3C). It
is worthmentioning that NPMblocks p53 from being transported
to the MT (Dhar and St Clair, 2009). Therefore, it would be of
A
C
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Figure 7. The Lymphoma-Associated RECQ4 ID Mutant Cannot Be
Regulated by MT p32
(A) The protein levels of NPM, p32, andRECQ4were analyzed onwestern blots
of WCE (top four panels) and MT (bottom two panels) prepared from HEK293T
cells that expressed either RECQ4 WT or ID proteins and were treated with
control, NPM, or p32 siRNA. Actin and VDAC1 were used as loading controls
for WCE and MT, respectively.
(B) Protein levels of RECQ4 and MCM10 in Cyt, MT, and NE/CB fractions
prepared from control or p32 siRNA-treated cells were analyzed on western
blots. MCM4, VDAC1, and Histone H3 were used as loading controls.
(C) Protein levels of p32 in Cyt, MT, and NE/CB fractions prepared from control
or NPM siRNA-treated cells were analyzed on western blots. Actin, VDAC1,
and Histone H3 were used as loading controls.
(D) The copy number of mtDNA relative to genomic DNA was quantified in
RECQ4 WT and ID cells that were transfected with control or p32 siRNA.
Results are represented as means ± SD from three independent experiments.great interest to test whether NPM prevents p53 MT trans-
port through its interaction with RECQ4. This possibility would
explain why p53 levels at the MT were unaffected in RECQ4 ID
cells, because the RECQ4 ID mutant remained capable of inter-
acting with NPM (Figure 6A).
In this study, we also revealed an unexpected functional inter-
action between p32 and NPM. We showed that NPM prevented
the loss of p32 in MT and its accumulation in the Cyt (Figure 7C).
Cumulative studies provide evidence that both NPM and p32
interact with the ARF tumor suppressor (Chen et al., 2010;
Itahana and Zhang, 2008), which is required for p53-mediated
apoptosis. p32 promotes ARF localization to the MT, which sen-
sitizes the cells to p53-induced apoptosis (Itahana and Zhang,
2008). In the nucleus, NPM abolishes ULF-mediated degrada-
tion of ARF to activate the p53-mediated stress response
(Chen et al., 2010). Further studies are needed to determine
whether NPM has a direct role in shuttling p32 from the Cyt tothe MT or the shuttling is indirectly regulated through common
interacting proteins, such as RECQ4 or ARF.
In summary, the importance of the interaction between p32
and RECQ4 is illustrated by the fact that the highly cancer-prone
RECQ4 IDmutant failed to interact with p32, leading to increases
in mtDNA copy number and MT dysfunction. Alterations to
mtDNA content in cells can have profound effects on aging
and human diseases, including cancers. This study provides
insight into the links between RECQ4 mutations and both aging
and cancer etiology.
EXPERIMENTAL PROCEDURES
Plasmids and Proteins
The shRNA expression plasmid pInduceMir3 was kindly provided by Dr. Ste-
phen J. Elledge (Harvard University). To generate the pInduceMir3-RECQ4-
shRNA plasmid, a DNA fragment containing the sequence 50-TGCTGTTGAC
AGTGAGCGCCGGCTCAACATGAAGCAGAAATAGTGAAGCCACAGATGTAT
TTCTGCTTCATGTTGAGCCGTTGCCTACTGCCTCGGA-30 was PCR ampli-
fied and cloned into pInduceMir3 between the XhoI and EcoRI sites. The
pCMV-FLAG-RECQ4 was generated as previously described (Xu et al.,
2009). The shRNA-resistant FLAG-RECQ4 expressing plasmid pCMV-
FLAG-RECQ4-R was generated by mutagenesis using the oligo 50-ACAGGG
GCAATTACGTTAGATTGAATATGAAACAAAAGCACTACGTGCGGGGCC-30,
and pCMV-FLAG-RECQ4 as the template. The mutagenesis primer 50-
CCAGTGTCCCCGGCCAGAGACGCCGGCTGAGG-30 was used to generate
shRNA-resistant pCMV-FLAG-RECQ4ID-R using pCMV-FLAG-RECQ4-R as
the template, and pET16b-RECQ4ID-FLAG using pET16b-RECQ4-FLAG
as the template (Xu and Liu, 2009). pET16b-RECQ(450-1208)-FLAG and
pET16b-RECQ4(1-492)-FLAG were generated as previously described (Xu
and Liu, 2009). The mutagenesis primer 50-GCCTACAGGTGCCGGCAGGT
CCCTGTGCTACCAGC-30 was used to generate pET16b-RECQ4ID(K508R)-
FLAG. To generate pGEX4T1-p32 or pGEX4T1-PEO1, p32 or PEO1 was PCR
amplified from the 293T cDNA library and cloned into pGEX4T-1 (GE Health-
care) between the EcoRI and XhoI sites. pGEX4T1-MCM10 was generated
as described previously (Xu et al., 2009). To generate pTXB1-PEO1, PEO1
was cloned into pTXB1 (New England BioLabs) between NdeI and XhoI sites.
N-terminal His-tagged and C-terminal FLAG-tagged WT RECQ4, RECQ4ID,
RECQID(K508R), RECQ(450-1208), and RECQ4(1-492) proteins were purified
as previously described (Xu and Liu, 2009). GST-p32, GST-PEO1, and GST
were purified as previously described for GST-MCM10 purification (Xu and
Liu, 2009). CBD-PEO1 and CBD were expressed in Rosetta (DE3) pLysS cells
by inducing with 0.1 mM isopropyl-b-D-thio-galactoside overnight at 4C. Cell
pellets were resuspended in buffer C (20 mM Tris pH8.0, 500 mM NaCl, 1 mM
EDTA, 0.1% Triton X-100) plus 0.2 mg/ml lysozyme and 13 protease inhibitor
cocktail (Roche), and lysed by sonication. After centrifugation, the supernatant
was incubated with Chitin beads (New England BioLabs) for 2 hr at 4C.
The beads were washed extensively with buffer C and stored in buffer B
(50 mM Tris pH 8.0, 300 mM NaCl, 50% glycerol, 1 mM dithiothreitol [DTT],
1% Triton X-100).
Antibodies
Rabbit anti-FLAG (F7425) was purchased from Sigma. Goat anti-Actin
(sc1616), mouse anti-p53 (DO-1) (sc-126), rabbit anti-NPM (sc-5564), rabbit
anti-Histone H3 (sc-10809), rabbit anti-CDC45 (sc-20685), mouse anti-
CDC6 (sc-9964), mouse anti-a tubulin (sc-8035), mouse anti-GST (sc-138),
and rabbit anti-Lamin A/C (sc-20681) were purchased from Santa Cruz. Rab-
bit anti-VDAC1 (ab15895) and rabbit anti-MCM7 (ab52489) were purchased
from Abcam. Rabbit anti-p32 (6502S) and rabbit anti-PP2Aa subunit
(2039S) were purchased from Cell Signaling Technology. Rabbit anti-
RECQ4 (2547.00.02) that was used in the coimmunoprecipitation experi-
ments (Figure 5C) and rabbit anti-SLD5 were purchased from Strategic
Diagnositics. Rat anti-BrdU (MCA2060T) was purchased from AbD Serotec.
Rabbit anti-MCM10 (12251-1-AP) and rabbit anti-PSF2 (16247-1-AP) were
purchased from Proteintech Group. Rabbit anti-MCM4 (A300-193A) wasCell Reports 7, 848–858, May 8, 2014 ª2014 The Authors 855
purchased from Bethyl Laboratories. Rabbit anti-PEO1 (ARP36483_P050)
was purchased from AVIVA Systems Biology. Mouse anti-p84 (GTX70220)
was purchased from GeneTex. Mouse anti-CBD (E80345) was purchased
from New England Biolabs. Rabbit anti-dimethyl-Histone H3 (Lys36) (07-
274) was purchased from Millipore. Rabbit anti-RECQ4 used in western
blot analyses (Figures 2A, 2C, 5C, S1, S2A, and S2C) was generated as pre-
viously described (Xu et al., 2009). Rabbit anti-MT single-stranded binding
protein (anti-mtSSB) was kindly provided by Dr. Valeria Tiranti (IRCCS
Foundation Neurological Institute, Milan, Italy).
Cell Culture, siRNA, and Cell Proliferation Assay
All cells were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum and streptomycin/penicillin (100 U/ml). NPM
stealth siRNA 50-UGCAAAGGAUGAGUUGCACAUUGUU-30 and p32 stealth
siRNA 50-GACGAGGCUGAGAGUGACAUCUUCU-30 were purchased from
Invitrogen. The siRNAs (25 nM) were transfected using DharmaFECT 1 trans-
fection reagent (Thermo Fisher Scientific) for 48 hr according to the manu-
facturer’s protocol. Stable shRNA-expressing cell lines were established
by transfecting the pInduceMir3 vector or pInduceMir3-RECQ4-shRNA,
and selecting with 2 mg/ml puromycin. To establish WT FLAG-RECQ4 and
ID stable 293T cell lines, the RECQ4 shRNA stable cell line was cotrans-
fected with pIREShyg3 (Clontech) and either pCMV-FLAG-RECQ4-R or
pCMV-FLAG-RECQ4ID-R plasmid, and then selected with 200 mg/ml hy-
gromycin. To establish WT FLAG-RECQ4 and ID stable U2OS and HT1080
cell lines, the RECQ4 shRNA stable cell line was transfected with pCMV-
FLAG-RECQ4-R or pCMV-FLAG-RECQ4ID-R plasmid, and then transformed
cells were selected using 400 mg/ml G418. Single clones were picked and
screened on western blots probed with the appropriate antibodies. Positive
clones were further amplified to establish stable cell lines. Crystal violet
cell proliferation assays were performed as previously described (Kueng
et al., 1989).
ATPase and DNA Strand-Exchange Assays
DNA unwinding assays were performed as previously described (Xu and Liu,
2009). The ATPase activity was measured by incubating the purified recom-
binant RECQ4 proteins with 8 pmol ssDNA and 2.5 3 102 mCi [g-32P] ATP in a
10 ml reaction containing ATPase buffer (30 mM Tris pH 7.5, 10% glycerol,
5 mM MgCl2, 50 mM cold ATP, 1 mM DTT, 100 mg/ml BSA) for 1 hr at
37C. The reactions were stopped by adding 5 ml of 0.5 M EDTA and sepa-
rated by PEI-cellulose thin-layer chromatography plate using a solution
of 0.8 M LiCl and 1 M formic acid, and incubation in a moist chamber
for 1.5 hr. The percentage of ATPase hydrolysis was quantified using a
phosphoimager.
Cell Fractionation, Immunopurification, and Mass Spectrometry
Analysis
Cells were fractionated into Cyt, NE, and benzonase-treated soluble CB
fractions as previously described (Xu et al., 2009). To isolate the MT fraction,
the cell pellet was resuspended in MT buffer (210 mM sucrose, 70 mM
mannitol, 1 mM EDTA, 1 mM EGTA, 1.5 mM MgCl2, 10 mM HEPES [KOH]
pH 7.2) that contained EDTA-free protease inhibitors and phosphatase in-
hibitors, and incubated on ice for 30 min. After homogenization, cell lysates
were centrifuged at 1,000 g for 5 min to pellet the intact cells and nuclei. The
supernatant was further centrifuged at 10,000 g to pellet the MT-enriched
heavy membrane fraction. The supernatant was collected as Cyt without
MT. The MT-enriched pellet was washed with MT buffer twice, resuspended
in MT lysis buffer (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 1 mM EDTA,
150 mM KCl, 0.1% NP40, 1 mM DTT, 10% glycerol) that contained
0.15 U/ml benzonase and EDTA-free protease inhibitors and phosphatase
inhibitors, sonicated, and incubated on ice for 1 hr. The supernatant was
collected as the MT fraction. For trypsin analysis, intact MT were isolated
and incubated with 100 mg/ml trypsin in MT buffer for 20 min on ice. The
trypsin-treated MT were recovered by centrifuging, and trypsin was inacti-
vated by adding 13 SDS-PAGE loading buffer. Immunopurification and
mass spectrometry analysis of the FLAG-tagged RECQ4 and the endoge-
nous RECQ4 complexes were performed as previously described (Xu
et al., 2009).856 Cell Reports 7, 848–858, May 8, 2014 ª2014 The AuthorsmtDNA Copy Number
Total cellular DNAwas isolated using the DNeasy Blood & Tissue Kit (QIAGEN).
Genomic DNA (Lamin B origin) and mtDNA (D-Loop) were quantified by real-
time PCR using the SYBR Green (Power) PCR Master Mix (Life Technologies)
and the ABI 7500 Fast Real-Time PCR System. All reactions were run in
triplicate. Relative mtDNA copy numbers were normalized with genomic
DNA (Lamin B origin). The D-loop PCR primers were 50-GTGGCTTTGGAGTTG
CAGTT-30 and 50-GAAGCAGATTTGGGTACCAC-30. The Lamin B origin
primers were 50-ATGAAGCGGATGTCTAAGAAAG-30 and 50-CGCCTGGGTCC
TGTTTACAC-30.
mtDNA Synthesis
RECQ4 shRNA-resistant expressing plasmids pCMV-FLAG-RECQ4-R and
pCMV-FLAG-RECQ4ID-R were transfected into RECQ4 shRNA cells with
continuum transfection reagent (Gemini Bio). After 48 hr, cells were further
incubated with or without 30 mM BrdU for 4 hr. To prepare mtDNA, cells
were harvested and MT were isolated as described above. The MT were
then resuspended in DNA isolation buffer (10 mM Tris pH 8.0, 10 mM EDTA,
0.5% SDS buffer, and 100 mg/ml protease K), incubated at 45C for 5 hr,
phenol-chloroform extracted, and ethanol precipitated. The presence of
genomic DNA contaminants was excluded by performing PCR analysis of
Lamin B gene using the primers 50-CTGCAGCTGGGGCTGGCATG-30 and
50-GACATCCGCTTCATTAGGGCAG-30 for the LAMIN B Ori locus (Xu et al.,
2009). The indicated amounts of mtDNA were blotted onto a nitrocellulose
membrane and vacuum dried for 2 hr at 80C as previously described (Brown,
2001). The membrane was then probed with mouse BrdU antibody (MD5100;
Invitrogen) and washed as for western blotting.
Metabolite Measurement
The metabolites from the cells transfected with RECQ4 WT and ID mutant
were extracted as previously described (Cano et al., 2010). The lyophilized,
water-soluble metabolites were resuspended in 100% D2O containing
3.2 mM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS), which served as
the 1H chemical-shift reference and an internal concentration standard. Three
replicates were prepared. NMR spectra were acquired at 25C on a Bruker
Avance III spectrometer equipped with a cryoprobe operating at a 700.243
MHz 1H frequency. 1H NMR spectra were acquired with water presaturation
during relaxation delay and using a spoil gradient over 32 k data points, spec-
tral width of 13 kHz, 3 s relaxation delay, and 2,048 scans. The NMR spectra
were processed using the Chenomx NMR Suite Processor (version 7.1; Che-
nomx). The Chenomx NMR Suite Profiler software was used to identify and
quantify the metabolites. The concentrations of the metabolites were con-
verted from micromolar units to nanomoles by multiplying the sample volume
and adjusting for the number of cells in the sample.
Protein Interactions In Vitro
GST, GST-p32, GST-PEO1, or GST-MCM10 (4 nmol) bound to glutathione
beads was blocked with 1 mg/ml BSA in buffer D (40 mM Tris pH 7.4,
10% glycerol, 0.1% Triton X-100, 1 mM EDTA, 150 mM NaCl, 1 mM DTT)
for 1 hr at 4C. His- and FLAG-tagged RECQ4 full-length (FL) and fragments
(0.4 nmol) were added and incubated for 2 hr at 4C. The bound proteins
were washed extensively with buffer D, boiled in SDS sample buffer, sepa-
rated by SDS-PAGE, and analyzed on western blots. For in vitro competition
assays, the His- and FLAG-tagged RECQ4 FL (0.5 nmol) were incubated
with or without p32 or MCM10 (0.5 nmol) in the presence of 2 mg BSA for
1.5 hr at 4C. They were then added to the BSA-blocked CBD of CBD-
PEO1 (0.5 nmol) bound chitin beads and incubated for another 1.5 hr at
4C. The bound proteins were washed extensively with buffer D, boiled in
SDS sample buffer, separated on SDS-PAGE, and analyzed on western
blots.
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